December 2025
1. FAUCI AS, Folkers GK
   Treatment and prevention of HIV/AIDS: Unfinished business.
   PLoS Med. 2025;22:e1004806.
   

   >> Share

   
   November 2025
2. OLBRICH L, Larsson L, Dunbar R, Dodd PJ, et al
   Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis.
   PLoS Med. 2025;22:e1004610.
   

   >> Share

   
   October 2025
3. TIWARI R, Singa BO, Lihanda P, Diakhate MM, et al
   Differences in growth trajectories in breastfed HIV-exposed uninfected and HIV-unexposed infants in Kenya: An observational cohort study.
   PLoS Med. 2025;22:e1004781.
   

   >> Share

   
   September 2025
4. SKRIVANKOVA VW, Rabie S, Tlali M, Folb N, et al
   Incidence and prognostic factors of self-harm and subsequent unnatural death in South Africa: A cohort study.
   PLoS Med. 2025;22:e1004765.
   

   >> Share

   
   
5. MUGWANY KK, Saina M, Mugo NR, MaWhinney S, et al
   Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study.
   PLoS Med. 2025;22:e1004732.
   

   >> Share

   
   
6. SIKOMBE K, Le Tourneau N, Rice B, Pry JM, et al
   Identifying care gaps along the HIV treatment failure cascade: A multistate analysis of viral load monitoring, re-suppression, and regimen switches in Zambia.
   PLoS Med. 2025;22:e1004720.
   

   >> Share

   
   August 2025
7. HUBER AN, Jamieson L, Fox MP, Manganye M, et al
   Evaluating the impact of differentiated service delivery (DSD) on retention in care and HIV viral suppression in South Africa: A target trial emulation using routine healthcare data.
   PLoS Med. 2025;22:e1004489.
   

   >> Share

   
   
8. TOH W, Lepine A, Gueye K, Fall MM, et al
   Effect of pre-exposure prophylaxis on risky sexual behaviour of female sex workers in Dakar, Senegal: A randomised controlled trial.
   PLoS Med. 2025;22:e1004458.
   

   >> Share

   
   July 2025
9. ADJOBIMEY M, Trajman A, Bastos ML, Valiquette C, et al
   Rapid molecular testing or chest X-ray or tuberculin skin testing for household contact assessment of tuberculosis infection: A cluster-randomized trial.
   PLoS Med. 2025;22:e1004666.
   

   >> Share

   
   June 2025
10. HICKEY MD, Owaraganise A, Ogachi S, Sang N, et al
    Community health worker-facilitated telehealth for moderate-severe hypertension care in Kenya and Uganda: A randomized controlled trial.
    PLoS Med. 2025;22:e1004632.
    

    >> Share

    
    May 2025
11. FERALDI A, Zarulli V, Buse K, Hawkes S, et al
    Sex-disaggregated data along the gendered health pathways: A review and analysis of global data on hypertension, diabetes, HIV, and AIDS.
    PLoS Med. 2025;22:e1004592.
    

    >> Share

    
    April 2025
12. SI Y, Guo L, Chen S, Zhang X, et al
    Progressing towards the 2030 health-related SDGs in ASEAN: A systematic analysis.
    PLoS Med. 2025;22:e1004551.
    

    >> Share

    
    January 2025
13. HICKEY MD, Ayieko J, Kabami J, Owaraganise A, et al
    Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: An individual-based modeling study.
    PLoS Med. 2025;22:e1004531.
    

    >> Share

    
    
14. KIM S, Can MH, Agizew TB, Auld AF, et al
    Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
    PLoS Med. 2025;22:e1004502.
    

    >> Share

    
    December 2024
15. GONZALEZ R, Nhampossa T, Figueroa-Romero A, Tchouatieu AM, et al
    Protecting the most vulnerable: The urgent need to include HIV-exposed children in malaria chemoprevention strategies.
    PLoS Med. 2024;21:e1004498.
    

    >> Share

    
    October 2024
16. PIPER JD, Mazhanga C, Mwapaura M, Mapako G, et al
    Growth, physical, and cognitive function in children who are born HIV-free: School-age follow-up of a cluster-randomised trial in rural Zimbabwe.
    PLoS Med. 2024;21:e1004347.
    

    >> Share

    
    
17. LEPINE A, Szawlowski S, Nitcheu E, Cust H, et al
    The effect of protecting women against economic shocks to fight HIV in Cameroon, Africa: The POWER randomised controlled trial.
    PLoS Med. 2024;21:e1004355.
    

    >> Share

    
    
18. HEITNER J, Mwenda V, Umutesi G, Barnabas RV, et al
    Leveraging behavioral economics strategies to close gaps in biomedical HIV prevention.
    PLoS Med. 2024;21:e1004475.
    

    >> Share

    
    September 2024
19. CALDERWOOD CJ, Marambire ET, Larsson L, Banze D, et al
    HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.
    PLoS Med. 2024;21:e1004452.
    

    >> Share

    
    August 2024
20. ODHIAMBO F, Onyango R, Mulwa E, Aluda M, et al
    Evaluation of person-centered interventions to eliminate perinatal HIV transmission in Kisumu County, Kenya: A repeated cross-sectional study using aggregated registry data.
    PLoS Med. 2024;21:e1004441.
    

    >> Share

    
    
21. GENG EH, Mocumbi A, Mutale W, Davila-Roman V, et al
    Primary care to further improve vertical HIV programming outcomes: From spillover to strategy.
    PLoS Med. 2024;21:e1004434.
    

    >> Share

    
    July 2024
22. BONNET G, Bimba J, Chavula C, Chifamba HN, et al
    Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
    PLoS Med. 2024;21:e1004429.
    

    >> Share

    
    
23. PINTO PFPS, Macinko J, Silva AF, Lua I, et al
    The impact of primary health care on AIDS incidence and mortality: A cohort study of 3.4 million Brazilians.
    PLoS Med. 2024;21:e1004302.
    

    >> Share

    
    June 2024
24. WALSH SR, Gay CL, Karuna ST, Hyrien O, et al
    Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.
    PLoS Med. 2024;21:e1004329.
    

    >> Share

    
    May 2024
25. EUVRARD J, Timmerman V, Keene CM, Phelanyane F, et al
    The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.
    PLoS Med. 2024;21:e1004407.
    

    >> Share

    
    
26. VAN DEN ELSHOUT MAM, Wijstma ES, Boyd A, Jongen VW, et al
    Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    PLoS Med. 2024;21:e1004328.
    

    >> Share

    
    
27. MICHALOW J, Walters MK, Edun O, Wybrant M, et al
    Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression.
    PLoS Med. 2024;21:e1004385.
    

    >> Share

    
    
28. TELISINGHE L, Floyd S, MacLeod D, Schaap A, et al
    Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2024;21:e1004393.
    

    >> Share

    
    April 2024
29. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    

    >> Share

    
    March 2024
30. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    

    >> Share

    
    
31. MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al
    Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
    PLoS Med. 2024;21:e1004360.
    

    >> Share

    
    
32. BRAZIER E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, et al
    Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
    PLoS Med. 2024;21:e1004367.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share